IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Evaxion Biotech A/S

CUSIP: 29970R204 | 14 institutional holders

Quarters

Q1 2026Q3 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Merck & Co., Inc.1,214,126
1.3% of portfolio›$4.5M
StyleTurnoverLocationFiled
Merck & Co., Inc.
1,214,126$4.5M1.3%GrowthLowRahway, NJ2026-05-13